- Research article
- Open Access
- Open Peer Review
A novel syndrome of paediatric cataract, dysmorphism, ectodermal features, and developmental delay in Australian Aboriginal family maps to 1p35.3-p36.32
© Hattersley et al; licensee BioMed Central Ltd. 2010
- Received: 23 June 2010
- Accepted: 19 November 2010
- Published: 19 November 2010
A novel phenotype consisting of cataract, mental retardation, erythematous skin rash and facial dysmorphism was recently described in an extended pedigree of Australian Aboriginal descent. Large scale chromosomal re-arrangements had previously been ruled out. We have conducted a genome-wide scan to map the linkage region in this family.
Genome-wide linkage analysis using Single Nucleotide Polymorphism (SNP) markers on the Affymetrix 10K SNP array was conducted and analysed using MERLIN. Three positional candidate genes (ZBTB17, EPHA2 and EPHB2) were sequenced to screen for segregating mutations.
Under a fully penetrant, dominant model, the locus for this unique phenotype was mapped to chromosome 1p35.3-p36.32 with a maximum LOD score of 2.41. The critical region spans 48.7 cM between markers rs966321 and rs1441834 and encompasses 527 transcripts from 364 annotated genes. No coding mutations were identified in three positional candidate genes EPHA2, EPHB2 or ZBTB17. The region overlaps with a previously reported region for Volkmann cataract and the phenotype has similarity to that reported for 1p36 monosomy.
The gene for this syndrome is located in a 25.6 Mb region on 1p35.3-p36.32. The known cataract gene in this region (EPHA2) does not harbour mutations in this family, suggesting that at least one additional gene for cataract is present in this region.
- Marker Single Nucleotide Polymorphism
- Preimplantation Genetic Diagnosis
- Single Nucleotide Polymorphism Array
- Facial Dysmorphism
The identification of genes for syndromic disorders not only provides insights into the cause and molecular pathology of disease but also advances our understanding of their normal function. Although technology has advanced to the point where large-scale genome-wide association studies for complex diseases are now feasible, family based disease gene discovery still plays an important role, particularly in identifying the genetic causes of Mendelian disease . Even in the case of rare syndromes, patients and families benefit from a clear molecular diagnosis which may assist with prognosis and clinical management as well as risk prediction enabling prenatal and preimplantation genetic diagnosis . In addition, novel disease gene discovery can lead to insights into the function of those genes and a better understanding of the underlying biology [3, 4]. Many syndromes have been described where the causative gene mutation has yet to be identified.
We recently described a novel phenotype in a large family of Australian Aboriginal descent . The phenotype is characterised by developmental delay, short stature, childhood onset cortical cataract, facial dysmorphism, clinodactyly, thin hair and an erythematous skin rash. The syndrome was identified in 5 male children, related at the level of second cousins. The two mothers of the 5 affected male children displayed only a mild cortical cataract not yet requiring surgery and are of short stature, but do not display the other features. The cataract in affected males was severe requiring surgery during early childhood. Initial inspection of the pedigree suggested X-linked inheritance. Linkage analysis of the X chromosome failed to detect any region of the chromosome identical-by-descent in the 5 children, excluding linkage from this chromosome  and therefore suggesting autosomal dominant inheritance. Thus we have conducted a genome-wide linkage analysis to localise the gene for this distinctive phenotype.
This project was approved by the Flinders Clinical Research Ethics Committee and the Research Ethics Committee of the Women's and Children's Hospital, Adelaide, South Australia. All participants and/or their guardian gave informed consent. As described previously , DNA was extracted from peripheral whole blood of all available family members. Simulations for maximum LOD score were conducted in SLINK . All clearly diagnosed cases and their parents and siblings (when available) were genotyped on the Affymetrix 10K SNP array at the Australian Genome Research Facility using standard protocols. This array contains ~10,000 Single Nucleotide Polymorphisms (SNPs). Due to uncertain affection status in individuals III:5, III:6 and IV:6, they were not included in the initial genome-wide scan. Linkage analysis was conducted using the MERLIN program . Any errors in the genotyping were detected using the error checking mode of MERLIN and removed using PEDWIPE before a multipoint linkage analysis was carried out. A fully penetrant autosomal dominant model was used with a rare disease frequency of 0.0001. Haplotypes were also reconstructed in MERLIN.
Six polymorphic SNPs that defined the haplotypes in the linked region were selected (rs580309, rs718206, rs720035, rs1416464, rs216036 and rs372151) and genotyped using SNaPshot® in all available family members to determine the carrier status of the linked region in untyped individuals. Previously typed individuals were also re-genotyped to ensure correlation between the two genotyping methods. Briefly, a primer directly adjacent to the polymorphic nucleotide was annealed to the PCR product, and a single fluorescently tagged ddNTP was incorporated according to the manufacturer's protocols (Applied Biosystems). The products were then electrophoresed on the ABI PRISM 3100 Genetic Analyzer to detect the alleles.
To identify genes from the linkage interval which are likely to be expressed in the eye, we searched the NEIbank database. Genes were classified as either not expressed in eye or expressed in one of three categories; "eye" (includes libraries from whole eye, retina, cornea etc), "fetal eye" and "lens". The categories were not exclusive. All genes expressed in "lens" are also in "eye".
Candidate genes were chosen from the linked region on the basis of putative function, expression pattern or association with congenital cataract. Primers were designed to amplify the coding exons (including splice sites) of each gene, and PCR products were directly sequenced on the ABI PRISM 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA) with BigDye Terminators (Applied Biosystems) according to standard protocols. Each exon was sequenced in two affected individuals, and sequences were compared to the reference sequence.
The 25.6 Mb linked region contains 531 transcripts from 364 RefSeq annotated genes extracted from the USCS Genome Browser, HG19. As cataract has been used as a characteristic feature on which to base the designation of "affected", the expression pattern of each gene in lens and fetal eye was investigated in silico through the resources of NEIbank. Of these genes, 136 are not reported to be expressed in eye tissue. Another 140 were found in eye tissues in general, 166 were reported in fetal eye libraries and 85 in the lens.
While selection of candidate genes from such a long list of positional candidates is difficult, we noted that one candidate gene in particular, ZBTB17 is expressed in skin as well as lens. Given the rash observed as part of this syndrome this gene became an attractive candidate. ZBTB17 (zinc-finger and BTB domain containing protein 17, myc-interacting protein 1) is a transcription factor that associates with the microtubules of the cytoskeleton , and interacts with the proto-oncogene myc . ZBTB17 activates gene transcription in response to changes in the cytoskeleton and in response to cell-cell adhesion formation [9, 11]. Correct cell adhesion and morphology is vital to maintaining the transparency of the ocular lens. ZBTB17 and myc interact to control the transcription of many genes . They are important in maintaining homeostasis of skin cells and keratinocytes, inducing skin stem cells to exit from the cell cycle and differentiate . All coding regions of the ZBTB17 gene were sequenced in two affected family members but no mutations were identified.
Recently, we and others reported that mutations in the EPHA2 gene cause both congenital [13, 14] and age-related cataract . The tendency of EPHA2 to be associated with the cortical subtype of cataract in adults was of particular interest as the affected members of this family displayed the unusual phenotype of juvenile onset progressive cortical cataract. EPHA2 is a receptor for ephrin-A5 (EFNA5). Mice deficient in EFNA5 also develop cataract . The eph-ephrin signalling pathways are involved in numerous cellular processes including cell morphogenesis, tissue patterning, cell migration, cell adhesion, cell proliferation and cell-fate determination. There are a variety of different EPH receptors and ephrin ligands. Also found within the linked region in this family is the EPHB2 gene, which along with the known cataract gene EPHA2 is a receptor for EFNA5. Thus, we directly sequenced all exons and intron-exon boundaries of both EPHA2 and EPHB2 in this family. No mutations were identified in either gene, indicating that coding mutations are not responsible for the phenotype in this family.
This study has identified a region on chromosome 1p36 linked to a distinctive phenotype consisting of cortical cataract, developmental delay, short stature, facial dysmorphism, clinodactyly, thin hair and an erythematous skin rash. Many other syndromes and diseases have also been shown to link to this region, some of which show significant phenotypic overlap with this family. Notably, terminal or interstitial deletions of 1p36 show a spectrum of features with marked similarity . Nearly 100% of such patients display mental retardation and developmental delay. Characteristic dysmorphic features observed in the majority of this group of patients include large anterior fontanelle, microcephaly, brachycephaly, dysmorphic ears, flat nasal bridge, pointed chin and clinodactyly. Conductive hearing loss is also reported and is present in the family reported here. It is highly probable that many of these overlapping features are contributed to by the deletion of the gene responsible for the phenotype in this family. Cataract is not commonly reported in 1p36 deletion patients, although other eye anomalies such as hypermetropia, myopia and strabismus are relatively common. This may be due to the effect of monosomy compared with a mutation that disrupts normal protein function.
It is highly unlikely that this family carries a contiguous gene deletion on 1p36 by virtue of the heterozygosity observed throughout the linked region in all affected individuals, although microdeletions in between markers cannot be ruled out. Array based comparative genomic hybridisation (aCGH) previously failed to identify any copy number variants with a resolution of 0.2-1.0 Mb . Ten of the 63 linked markers show homozygosity in all affected individuals but only two of these markers are contiguous (rs2319403 and rs2319404). These two SNPs are located only 131 bp apart in an intron of the PTPRU gene. This gene is a plausible candidate as it is reported to be expressed in the crystalline lens and is involved in cell-cell adhesions, interacting with beta-catenin and E cadherin . The next flanking heterozygous markers define a region of nearly 380 kb containing five genes (EPB41, TMEM200B, SFRS4, MECR and PTPRU) all of which are expressed in lens. A microdeletion in this region encompassing the two homozygous markers and thus disrupting at least the PTPRU gene cannot be completely ruled out with this methodology.
The number of potential candidate genes for this phenotype in the linked region is very large. While expression information is useful in prioritising genes for analysis, the number of genes to assess in this particular case remains large, and expression profiles generated by EST libraries and micorarray information are not exhaustive, meaning even more genes are potential candidates. It was initially thought that this pedigree displayed X-linked inheritance, due to a milder phenotype observed in females III:2 and III:9. However, a thorough evaluation of the X chromosome ruled out this possibility , which was confirmed by re-analysis of the X chromosome in this genome-wide study. The reason for the differential expression in the females of generation III and the males of generation IV is not clear. Anticipation may be an explanation for generational differences. It is also possible that the gene responsible is regulated differently in males and females or that the gene product interacts with other factors (eg sex hormones) present at different levels in males and females. Alternatively, the genetic background may be important for phenotype expression, with cousins III:2 and III:9 carrying a common inherited protective allele at an independent interacting locus not passed on to the affected offspring.
We have localised the region for a novel phenotype characterised by cataract, mental retardation, erythematous rash and facial dysmorphism to a region on chromosome 1p36. Further evaluation of all linked genes is required to identify the causative gene.
This work was funded by the National Health and Medical Research Council (NHMRC) of Australia. KPB is an NHMRC Career Development Award Fellow, JEC an NHMRC Practitioner Fellow and JG an NHMRC Research Fellow.
- Check Hayden E: Genomics shifts focus to rare diseases. Nature. 2009, 461 (7263): 458-10.1038/461458a.View ArticlePubMedGoogle Scholar
- Reches A, Yaron Y, Burdon K, Crystal-Shalit O, Kidron D, Malcov M, Tepper R: Prenatal detection of congenital bilateral cataract leading to the diagnosis of Nance-Horan syndrome in the extended family. Prenat Diagn. 2007, 27 (7): 662-664. 10.1002/pd.1734.View ArticlePubMedGoogle Scholar
- Burdon KP, McKay JD, Sale MM, Russell-Eggitt IM, Mackey DA, Wirth MG, Elder JE, Nicoll A, Clarke MP, FitzGerald LM, et al: Mutations in a novel gene, NHS, cause the pleiotropic effects of Nance-Horan syndrome, including severe congenital cataract, dental anomalies, and mental retardation. Am J Hum Genet. 2003, 73 (5): 1120-1130. 10.1086/379381.View ArticlePubMedPubMed CentralGoogle Scholar
- Sharma S, Ang SL, Shaw M, Mackey DA, Gecz J, McAvoy JW, Craig JE: Nance-Horan syndrome protein, NHS, associates with epithelial cell junctions. Hum Mol Genet. 2006, 15 (12): 1972-1983. 10.1093/hmg/ddl120.View ArticlePubMedGoogle Scholar
- Burdon KP, Durkin SR, Burke M, Edwards M, Pater J, Straga T, Gecz J, Liebelt JE, Craig JE: A novel genetic syndrome characterized by pediatric cataract, dysmorphism, ectodermal features, and developmental delay in an indigenous Australian family. Am J Med Genet A. 2009, 149A (4): 633-639. 10.1002/ajmg.a.32726.View ArticlePubMedGoogle Scholar
- Weeks DE, Ott J, Lathrop GM: SLINK: a general simulation program for linkage analysis. Am J Hum Genet. 1990, 47 (3): A204-(Supplement)Google Scholar
- Abecasis GR, Cherny SS, Cookson WO, Cardon LR: Merlin--rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet. 2002, 30 (1): 97-101. 10.1038/ng786.View ArticlePubMedGoogle Scholar
- NEIbank. [http://neibank.nei.nih.gov/index.shtml]
- Ziegelbauer J, Shan B, Yager D, Larabell C, Hoffmann B, Tjian R: Transcription Factor MIZ-1 Is Regulated via Microtubule Association. Molecular Cell. 2001, 8 (339-349):Google Scholar
- Patel JH, McMahon SB: Targeting of Miz-1 Is Essential for Myc-mediated Apoptosis*. Journal of Biological Chemistry. 2006, 281 (6): 3283-3289. 10.1074/jbc.M513038200.View ArticlePubMedGoogle Scholar
- Ziegelbauer J, Wei J, Tjian R: Myc-interacting protein 1 target gene profile: A link to microtubules, extracellular signal-regulated kinase, and cell growth. PNAS. 2003, 101 (2): 458-463. 10.1073/pnas.0307562100.View ArticleGoogle Scholar
- Gebhardt A, Frye M, Herold S, Benitah SA, Braun K, Samans B, Watt FM, Elsässer H, Eilers M: Myc regulates keratinocyte adhesion and differentiation via complex formation with Miz1. Journal of Cell Biology. 2006, 172 (1): 139-149. 10.1083/jcb.200506057.View ArticlePubMedPubMed CentralGoogle Scholar
- Shiels A, Bennett TM, Knopf HL, Maraini G, Li A, Jiao X, Hejtmancik JF: The EPHA2 gene is associated with cataracts linked to chromosome 1p. Mol Vis. 2008, 14: 2042-2055.PubMedPubMed CentralGoogle Scholar
- Zhang T, Hua R, Xiao W, Burdon KP, Bhattacharya SS, Craig JE, Shang D, Zhao X, Mackey DA, Moore AT, et al: Mutations of the EPHA2 receptor tyrosine kinase gene cause autosomal dominant congenital cataract. Hum Mutat. 2009, 30 (5): E603-611. 10.1002/humu.20995.View ArticlePubMedGoogle Scholar
- Jun G, Guo H, Klein BE, Klein R, Wang JJ, Mitchell P, Miao H, Lee KE, Joshi T, Buck M, et al: EPHA2 is associated with age-related cortical cataract in mice and humans. PLoS genetics. 2009, 5 (7): e1000584-10.1371/journal.pgen.1000584.View ArticlePubMedPubMed CentralGoogle Scholar
- Cooper MA, Son AI, Komlos D, Sun Y, Kleiman NJ, Zhou R: Loss of ephrin-A5 function disrupts lens fiber cell packing and leads to cataract. Proc Natl Acad Sci USA. 2008, 105 (43): 16620-16625. 10.1073/pnas.0808987105.View ArticlePubMedPubMed CentralGoogle Scholar
- Gajecka M, Mackay KL, Shaffer LG: Monosomy 1p36 deletion syndrome. Am J Med Genet C Semin Med Genet. 2007, 145C (4): 346-356. 10.1002/ajmg.c.30154.View ArticlePubMedGoogle Scholar
- Wang H, Lian Z, Lerch MM, Chen Z, Xie W, Ullrich A: Characterization of PCP-2, a novel receptor protein tyrosine phosphatase of the MAM domain family. Oncogene. 1996, 12 (12): 2555-2562.PubMedGoogle Scholar
- Hittner HM, Kretzer FL, Mehta RS: Zellweger syndrome. Lenticular opacities indicating carrier status and lens abnormalities characteristic of homozygotes. Arch Ophthalmol. 1981, 99 (11): 1977-1982.View ArticlePubMedGoogle Scholar
- Shimozawa N, Tsukamoto T, Nagase T, Takemoto Y, Koyama N, Suzuki Y, Komori M, Osumi T, Jeannette G, Wanders RJ, et al: Identification of a new complementation group of the peroxisome biogenesis disorders and PEX14 as the mutated gene. Hum Mutat. 2004, 23 (6): 552-558. 10.1002/humu.20032.View ArticlePubMedGoogle Scholar
- Eiberg H, Lund AM, Warburg M, Rosenberg T: Assignment of congenital cataract Volkmann type (CCV) to chromosome 1p36. Hum Genet. 1995, 96 (1): 33-38. 10.1007/BF00214183.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2350/11/165/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.